Has Mutations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Has Mutations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Has Mutations Today - Breaking & Trending Today

Olaparib Plus Selumetinib Produces Clinical Benefit in RAS-Mutated Ovarian and Endometrial Cancer

Published: March 27, 2023

The recommended phase 2 dose of olaparib plus selumetinib generated a clinical benefit in patients with endometrial or ovarian cancer harboring RAS mutations, according to findings from the dose-expansion portion of the phase 1b SOLAR trial.

Source: onclive.com

Related Topics:

United StatesShannonn WestinSociety Of Gynecologic OncologyDepartment Of Gynecologic OncologyUniversity Of Texas Md Anderson Cancer CenterDivision Of SurgeryGynecologic OncologyAnnual MeetingReproductive MedicineCancer CenterOvarian CancerEndometrial CancerHas MutationsPhase 1b Dose ExpansionSolar TrialBrca Mutations